Literature DB >> 8819046

Characterization of hepatoportal microvascular dysplasia in a kindred of cairn terriers.

T Schermerhorn1, S A Center, N L Dykes, P H Rowland, A E Yeager, H N Erb, K Oberhansley, M Bonda.   

Abstract

Hepatoportal microvascular dysplasia (MVD), a congenital disorder of the hepatic vasculature, is described in a kindred of Cairn Terrier dogs. Cairn Terrier dogs (n = 165) were evaluated using the serum bile acid test. Affected dogs, identified by abnormal fasting or postprandial serum bile acid concentrations, were divided into 2 groups. Group 1 dogs (n = 147) were used for pedigree analysis. Group 2 dogs (n = 18) were characterized on the basis of history, physical examination, clinicopathologic studies, diagnostic imaging of the liver and portal circulation, and hepatic histopathology. Group 2 contained control dogs (n = 2), dogs with hepatoportal MVD (n = 11), and dogs with macroscopic portosystemic vascular anomalies (PVSA) (n = 5). With the exception of high serum bile acid concentrations, dogs with hepatoportal MVD were indistinguishable from control dogs on the basis of history, physical examination, clinicopathologic findings, survey abdominal radiography, abdominal ultrasound, or transcolonic scintigraphy. Contrast portography in dogs with MVD revealed abnormalities of terminal twigs of the portal vasculature with out large intrahepatic or extrahepatic shunting vessels. Histopathologic abnormalities in dogs with hepatoportal MVD were similar to those reported for dogs with PSVA. Pedigree analysis suggested an autosomal inheritance for MVD. Dogs with MVD had high serum bile acid concentrations, abnormal indocyanine green clearance, and hepatic pathology suggestive of PSVA, but they lacked characteristic clinical findings of PSVA. The clinical significance of MVD is unclear. Dogs with MVD were clinically normal when evaluated but long-term follow-up is not yet available. Dogs with hepatoportal MVD should be identified at an early age to avoid confusion in future diagnostic evaluations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8819046     DOI: 10.1111/j.1939-1676.1996.tb02053.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  8 in total

1.  Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice.

Authors:  G P Lahvis; S L Lindell; R S Thomas; R S McCuskey; C Murphy; E Glover; M Bentz; J Southard; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Primary portal vein hypoplasia and SLC2A9 mutation associated with urate urolithiasis in a Spanish water dog.

Authors:  Laura Cosgrove; Gawain Hammond; Gerard Mclauchlan
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

3.  A hypomorphic allele of aryl hydrocarbon receptor-associated protein-9 produces a phenocopy of the AHR-null mouse.

Authors:  Bernice C Lin; Linh P Nguyen; Jacqueline A Walisser; Christopher A Bradfield
Journal:  Mol Pharmacol       Date:  2008-07-31       Impact factor: 4.436

4.  Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using Oil Red O staining.

Authors:  G B Hunt; J A Luff; L Daniel; R Van den Bergh
Journal:  Vet Pathol       Date:  2013-03-25       Impact factor: 2.221

5.  Clinicopathological Findings and Prognosis in Canine Cases Diagnosed As Primary Hypoplasia of the Portal Vein.

Authors:  Makoto Akiyoshi; Masaharu Hisasue; Masami Akiyoshi
Journal:  Front Vet Sci       Date:  2017-12-21

6.  Retrospective Liver Histomorphological Analysis in Dogs in Instances of Clinical Suspicion of Congenital Portosystemic Shunt.

Authors:  Małgorzata Sobczak-Filipiak; Józef Szarek; Iwona Badurek; Jessica Padmanabhan; Piotr Trębacz; Monika Januchta-Kurmin; Marek Galanty
Journal:  J Vet Res       Date:  2019-06-12       Impact factor: 1.744

7.  Persistent hypercobalaminemia three months after successful gradual attenuation of extrahepatic shunts in dogs: a prospective cohort study.

Authors:  Nausikaa Devriendt; Gonçalo Serrano; Dominique Paepe; Sophie Vandenabeele; Emmelie Stock; Hilde de Rooster
Journal:  BMC Vet Res       Date:  2022-01-06       Impact factor: 2.741

8.  Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor.

Authors:  Maureen K Bunger; Edward Glover; Susan M Moran; Jacqueline A Walisser; Garet P Lahvis; Erin L Hsu; Christopher A Bradfield
Journal:  Toxicol Sci       Date:  2008-07-27       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.